In April 2015, a woman from Randolph, Norfolk County, Massachusetts, filed a lawsuit against the manufacturer of the pharmaceutical drug Zofran, alleging that the prescription drug caused severe abdominal malformations in her unborn child which eventually lead to the death of her child in utero, causing the plaintiff severe pain and suffering. This is another lawsuit facing GlaxoSmithKline in the United States where families are seeking justice on the basis that several studies performed by the medical community has suggested an association between the drug and congenital defects. To read a summary of all the recent case filings in the Zofran litigation, click here.
To view the original complaint filed in this matter, click on the button below.
Did Zofran Cause Abdominal Malformations Resulting In Miscarriage/In Utero Death?
The plaintiff in this case was pregnant in 2013. In order to alleviate her severe symptoms of morning sickness, the plaintiff was prescribed Zofran, which she took during the first trimester. Not too long after, the a scan diagnosed the plaintiff’s unborn baby with severe and life-threatening fetal defects, which included severe malformations of the abdomen. The plaintiff was left with the only medical option of having to terminate her pregnancy, and her unborn baby died in utero on October 16, 2013.
This is the first complaint filed by a mother who lost her unborn child as a result of life-threatening fetal defects, which ultimately lead to a miscarriage. The complaint alleges that Zofran was the proximate cause of the abdominal malformations, which resulted in severe and ongoing pain, distress, and suffering of the Plaintiff.
The Basis Of The Lawsuit Against Zofran
The complaint, filed in federal court, also summarized the latest studies associating Zofran with child birth defects:
- 2.37 times increased risk of cleft palate;
- 2 times increased risk of heart defect; and
- 20% increased risk of any birth defect.
Birth Defects Named In Zofran Lawsuits To Date
As of April 2015, there have been seven lawsuits filed against GlaxoSmithKline alleging child birth defects. The complaints have blamed the following birth defects on taking the drug during the first trimester of pregnancy for morning sickness.
- abdominal malformations
- cleft palate
- supraventricular tachycardia
- aortic bicuspid stenosis
- atrial septal defect
- atrioventricular septal defect
- aortic arch hypoplasia
- ventricular hypertension
- facial dysmorphia
- clubbed foot
- kidney malformations
For more information about the zofran litigation in Massachusetts, you can visit our page with information pertaining to the state. You will find information on child birth defect statistics, and summaries of all lawsuits filed alleging that Zofran was the proximate cause of a child birth defect by MA based families. Click here for more information.